| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $12.39 ▲ +1.33% | Yesterday | $12.16 ▼ -0.56% | Tomorrow's NovoCure Limited Ordinary Shares (NVCR) setup is anchored to $12.23 and targets $12.39 (+1.33%). The near-term read is upside; watch $12.60 / $11.86 because daily realized volatility is about 6.84%. |
Tomorrow's NovoCure Limited Ordinary Shares (NVCR) setup is anchored to $12.23 and targets $12.39 (+1.33%). The near-term read is upside; watch $12.60 / $11.86 because daily realized volatility is about 6.84%. | ||||
| Week | $12.73 ▲ +4.12% | Last Week | $12.02 ▼ -1.73% | The 7-day NovoCure Limited Ordinary Shares model moves from $12.02 to $12.73 (+4.12%). It gives upside momentum context for this stock, so breaks around $12.60 / $11.86 matter more than a single tick. |
The 7-day NovoCure Limited Ordinary Shares model moves from $12.02 to $12.73 (+4.12%). It gives upside momentum context for this stock, so breaks around $12.60 / $11.86 matter more than a single tick. | ||||
| Month | $13.30 ▲ +8.79% | Last Month | $11.78 ▼ -3.69% | The 1-month NovoCure Limited Ordinary Shares target is $13.30 (+8.79%), compared with the live reference near $12.23. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month NovoCure Limited Ordinary Shares target is $13.30 (+8.79%), compared with the live reference near $12.23. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $14.16 ▲ +15.77% | Last Year | $11.42 ▼ -6.62% | The 1-year NovoCure Limited Ordinary Shares scenario points to $14.16 (+15.77%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year NovoCure Limited Ordinary Shares scenario points to $14.16 (+15.77%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $16.16 ▲ +32.14% | 5 Years Ago | $10.58 ▼ -13.50% | The 5-year NovoCure Limited Ordinary Shares view is $16.16 (+32.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year NovoCure Limited Ordinary Shares view is $16.16 (+32.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $12.23 | Mid |
| Daily Change | -3.47% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 65% | Above |
| Data Source | nasdaq-screener | Mid |
| Current | $12.23 | Daily Change | -3.47% |
| Market Cap | $1.39B | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.